Cover Image

FDA facing challenges: GAO

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	The Brown University Child & Adolescent Psychopharmacology Update
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FDA lifts bans on fruit vapes
Published: (2026)

From the FDA: Nicotine pouches can be dangerous to children
Published: (2025)

FDA urges higher naloxone doses in fentanyl era
by: Alison Knopf
Published: (2024)

Reorganizing the FDA is not a good idea: Former officials
Published: (2025)

FDA approves drug to treat neurologic manifestations of Hunter syndrome
Published: (2026)

Ob‐gyns respond to recent FDA discussion on SSRIs in pregnancy
by: Alison Knopf
Published: (2025)

FDA warns against accidental overdose on fentanyl patches by children
by: Alison Knopf
Published: (2024)

FDA warns against ultra‐processed food risks to children
Published: (2025)

FDA requests removal of suicide warnings from two GLP‐1 labels
Published: (2026)

Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response
Published: (2025)

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
by: Alison Knopf
Published: (2026)

FDA approves first genetic test to help identify risk of developing opioid use disorder
Published: (2024)

Methylphenidate for ADHD found to have effects on stature and BMI
by: Alison Knopf
Published: (2026)

Assess the family to help the child – and the family
by: Alison Knopf
Published: (2026)

Contraindicated psychotropic medication use widespread
by: Alison Knopf
Published: (2026)

HHS critical of “overprescribing” psychiatric medications to children
by: Alison Knopf
Published: (2026)

Teens with close families less likely to be lonely adults
by: Alison Knopf
Published: (2026)

Psychopathology risk in mid‐adolescence increased by multiple prenatal adversities
by: Alison Knopf
Published: (2026)

Loneliness in early adolescence associated with increased risk for mental disorders
by: Alison Knopf
Published: (2026)

NY takes steps to rein in youth gambling
by: Alison Knopf
Published: (2026)

International group adds new items focusing on pediatrics in trials
by: Alison Knopf
Published: (2026)

Study suggests glutamate receptor may help differentiate autism varieties
by: Alison Knopf
Published: (2026)

Researchers urge slow tapers in deprescribing study for pediatrics
by: Alison Knopf
Published: (2026)

ASAM releases new criteria for adolescents and youth
by: Alison Knopf
Published: (2026)

What is CBD: Regulators still have questions even as marijuana is rescheduled
Published: (2026)

Patient Information Sheet
by: Alison Knopf
Published: (2026)

Patient Information Sheet
by: Alison Knopf
Published: (2026)

Lead exposure associated with depression during later childhood
by: Alison Knopf
Published: (2026)

Where autism is prevalent and insurance is generous, private equity buys
by: Alison Knopf
Published: (2026)

Researchers: Opioid treatment medications only work if patients take them
by: Alison Knopf
Published: (2026)

Literature review: Melatonin use by young children should be reduced or prevented
by: Alison Knopf
Published: (2026)

Psychotic‐like experiences found predictive of half of mental disorders
by: Alison Knopf
Published: (2026)

Study recommends symptom‐based dosing for NOWS
by: Alison Knopf
Published: (2026)

Patient Information Sheet
by: Alison Knopf
Published: (2026)

President Trump moves marijuana to Schedule III
by: Alison Knopf
Published: (2026)

Screens harmful to youth sleep
by: Alison Knopf
Published: (2026)

Substance use screening urged in EDs for youth in crisis
by: Alison Knopf
Published: (2026)

Patient Information Sheet
by: Alison Knopf
Published: (2026)

Researchers find possible biomarker for pediatric anxiety
by: Alison Knopf
Published: (2026)

Patient Information Sheet
by: Alison Knopf
Published: (2026)